InvestSMART

Emerald Resources NL (ASX: EMR) - Announcements

Current share price for EMR : $6.630 0.15 (2.21%)+

ASX company news and announcements for Emerald Resources NL (EMR) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Emerald Resources NL (EMR) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Emerald Resources NL (EMR), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Emerald Resources NL (EMR)

Market Cap ($m) Headline Release
date/time+
Price at
release+
Current
price+
Gain/Loss View
$4,399 Second Supplementary Target's Statement 15 Feb 2024 8:15AM $3.140 $6.630 risen by 111.15%
$4,399 Application for quotation of securities - EMR 9 Feb 2024 6:19PM $3.030 $6.630 risen by 118.81%
$4,399 Application for quotation of securities - EMR 9 Feb 2024 4:29PM $3.030 $6.630 risen by 118.81%
$4,399 Option Exercise 9 Feb 2024 4:27PM $3.030 $6.630 risen by 118.81%
$4,399 Application for quotation of securities - EMR 1 Feb 2024 4:51PM $3.060 $6.630 risen by 116.67%
$4,399 Option Exercise 1 Feb 2024 4:51PM $3.060 $6.630 risen by 116.67%
$4,399 Quarterly Report 30 Jan 2024 8:17AM $3.410 $6.630 risen by 94.43%
$4,399 Recommended and Unconditional Takeover Offer Extended 25 Jan 2024 8:29PM $3.260 $6.630 risen by 103.37%
$4,399 Significant Exploration Results Continue at EMR Prospects 24 Jan 2024 8:54AM $3.180 $6.630 risen by 108.49%
$4,399 Application for quotation of securities - EMR 19 Jan 2024 5:51PM $3.160 $6.630 risen by 109.81%
$4,399 Application for quotation of securities - EMR 12 Jan 2024 5:53PM $3.200 $6.630 risen by 107.19%
$4,399 Another Impressive Quarter - Okvau Quarterly Gold Production 8 Jan 2024 9:03AM $2.990 $6.630 risen by 121.74%
$4,399 Application for quotation of securities - EMR 5 Jan 2024 3:20PM $2.985 $6.630 risen by 122.11%
$4,399 Recommended and Unconditional Takeover Offer Extended 29 Dec 2023 6:41PM $3.010 $6.630 risen by 120.27%
$4,399 Application for quotation of securities - EMR 29 Dec 2023 3:01PM $3.010 $6.630 risen by 120.27%
$4,399 Application for quotation of securities - EMR 22 Dec 2023 7:08PM $3.070 $6.630 risen by 115.96%
$4,399 Maiden Memot Gold Project Resource Statement 21 Dec 2023 8:27AM $3.110 $6.630 risen by 113.18%
$4,399 Application for quotation of securities - EMR 18 Dec 2023 7:24PM $2.860 $6.630 risen by 131.82%
$4,399 Option Exercise 18 Dec 2023 7:21PM $2.860 $6.630 risen by 131.82%
$4,399 Application for quotation of securities - EMR 18 Dec 2023 7:17PM $2.860 $6.630 risen by 131.82%
$4,399 Modern Slavery Statement 12 Dec 2023 5:42PM $2.590 $6.630 risen by 155.98%
$4,399 Application for quotation of securities - EMR 8 Dec 2023 5:42PM $2.560 $6.630 risen by 158.98%
$4,399 Change in substantial holding 7 Dec 2023 8:18AM $2.690 $6.630 risen by 146.47%
$4,399 Application for quotation of securities - EMR 1 Dec 2023 6:35PM $2.800 $6.630 risen by 136.79%
$4,399 Option Exercise 1 Dec 2023 6:33PM $2.800 $6.630 risen by 136.79%

301 - 325 of 1043 results

Page 13 of 42

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.